Cargando…
Parenteral anticoagulation may prolong the survival of patients with limited small cell lung cancer: a Cochrane systematic review
BACKGROUND: To determine the efficacy and safety of heparin (unfractionated heparin (UFH) or low-molecular-weight-heparin (LMWH)) and fondaparinux in improving the survival of patients with cancer. METHODS: We conducted in January 2007 a comprehensive search for relevant randomized clinical trials (...
Autores principales: | Akl, Elie A, van Doormaal, Frederiek F, Barba, Maddalena, Kamath, Ganesh, Kim, Seo Young, Kuipers, Saskia, Middeldorp, Saskia, Yosuico, Victor, Dickinson, Heather O, Schünemann, Holger J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2438335/ https://www.ncbi.nlm.nih.gov/pubmed/18577254 http://dx.doi.org/10.1186/1756-9966-27-4 |
Ejemplares similares
-
Low-molecular-weight heparins are superior to vitamin K antagonists for the long term treatment of venous thromboembolism in patients with cancer: a cochrane systematic review
por: Akl, Elie A, et al.
Publicado: (2008) -
Assessing and presenting summaries of evidence in Cochrane Reviews
por: Langendam, Miranda W, et al.
Publicado: (2013) -
Systematic evaluation of the methodology of randomized controlled trials of anticoagulation in patients with cancer
por: Rada, Gabriel, et al.
Publicado: (2013) -
An instrument to assess quality of life in relation to nutrition: item generation, item reduction and initial validation
por: Schünemann, Holger J, et al.
Publicado: (2010) -
An anticoagulant that does not cause bleeding – an abrupt stop on the road to the Holy Grail
por: Meijers, Joost C. M., et al.
Publicado: (2019)